American Well Corporation ((AMWL)) has held its Q4 earnings call. Read on for the main highlights of the call.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
During the latest earnings call of American Well Corporation, a mix of optimism and acknowledgment of challenges was evident. The company showcased significant achievements in strategic deployments and financial improvements, which were counterbalanced by concerns over visit metrics and a one-time expense issue. Despite these hurdles, the leadership expressed strong confidence in Amwell’s growth trajectory and strategic initiatives.
Military Health System Deployment
Amwell’s deployment of its full solution across the Military Health System marks a pivotal growth initiative, the most significant in the company’s history. This stage launch is expected to be a cornerstone for future growth as it expands its reach and capability within the healthcare sector.
Subscription Revenue Growth
The company reported a robust 36% year-over-year growth in subscription revenue for Q4. This increase was largely driven by strategic client deployments, notably the Military Health System, indicating a successful expansion strategy that enhances recurring revenue streams.
Improved Adjusted EBITDA
Amwell demonstrated significant progress towards profitability with a 60% improvement in adjusted EBITDA year-over-year. This improvement underscores the company’s commitment to financial health and operational efficiency.
Expansion of Leadership Roles
In a strategic move to enhance company focus and efficiency, Mark Hirschhorn’s role was expanded from CFO to include Chief Operating Officer. This change is aimed at optimizing leadership and operational effectiveness.
Divestiture of Non-Core Assets
Amwell’s decision to sell Amwell Psychiatric Care for up to $30 million in cash is a strategic shift to concentrate on its core platform. This divestiture is expected to strengthen the company’s balance sheet, providing more liquidity for future initiatives.
Decline in Visit Metrics
The company experienced a decline in visit metrics, with approximately 1.4 million visits completed in Q4, marking an 18% decrease from the previous year. This decline was attributed to market-wide softness and client execution challenges.
One-Time Bad Debt Accrual
A significant one-time bad debt accrual related to a cyber event led to a 38% increase in G&A expenses. This unexpected expense was a notable concern during the earnings call.
Flat Total Revenue
Total revenue for Q4 remained flat at $71 million compared to the previous year. While other areas showed growth, this stagnation highlighted areas needing attention and improvement.
Forward-Looking Guidance
Looking ahead to 2025, Amwell projects total revenue to fall between $250 million and $260 million, with subscription revenue making up nearly 60% of this figure. The company plans to enhance its software offerings and improve adjusted EBITDA by over 60%, aiming to achieve positive cash flow by 2026. Strategic cost reductions and the positive impact of the divestiture are expected to support these goals, alongside the continued deployment across the Military Health System.
In conclusion, the earnings call painted a picture of a company in transition, with strong strategic initiatives driving growth and efficiency improvements. However, challenges such as decreased visit metrics and specific financial setbacks were acknowledged. Overall, Amwell remains optimistic about its future, guided by a robust plan to enhance its core offerings and financial performance.
